Comparative effectiveness of preoperative, postoperative and perioperative treatments for resectable gastric cancer: A network meta-analysis of the literature from the past 20 years-Reference-Cited by-同舟云学术

Comparative effectiveness of preoperative, postoperative and perioperative treatments for resectable gastric cancer: A network meta-analysis of the literature from the past 20 years

Published:2018-09 Issue:3 Volume:27 Page:563-574
ISSN:0960-7404
Container-title:Surgical Oncology
language:en
Short-container-title:Surgical Oncology

Author:

Cai Zhaolun^ORCID,Yin Yuan,Shen Chaoyong,Wang Jian,Yin Xiaonan,Chen Zhixin,Zhou Ye,Zhang Bo^ORCID

Publisher

Elsevier BV

Subject

Oncology,Surgery

Reference64 articles.

1. Global cancer statistics;Jemal;CA A Cancer J. Clin.,2011

2. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study;De Angelis;Lancet Oncol.,2014

3. Patterns of initial recurrence in completely resected gastric adenocarcinoma;Dangelica;Ann. Surg.,2004

4. Gastric cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology;Ajani;J. Natl. Compr. Canc. Netw.,2016

5. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis;Paoletti;Jama,2010

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological Activity of Natural and Synthetic Peptides as Anticancer Agents;International Journal of Molecular Sciences;2024-07-01

2. The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines;Journal of Peptide Science;2024-04-03

3. Evaluation of the efficacy and safety of ramucirumab combined with nab-paclitaxel, lobaplatin, and S-1 in neoadjuvant and conversion therapy for advanced gastric cancer: A study protocol of prospective single-center, randomized controlled and open label clinical trial (RNPLS-01);Heliyon;2024-04

4. Neoadjuvant and/or adjuvant chemotherapy for gastric cancer patients with microsatellite instability or deficient mismatch repair: a systematic review and meta-analysis study protocol;BMJ Open;2024-04

5. Aggressive HER2-Positive Gastric Cancer in a Young Patient, Refractory in Trastuzumab and Progressive with Trastuzumab-Emtansine Treatment;International Journal of Biomedicine;2024-03-01